Loading page…
Healthcare
Amgen Inc. attains an AlphaScore of 58/100 within the Healthcare sector, supported by a market capitalization of $224.29 billion. Notable metrics feature a very high return on equity of 89.06% and a solid gross margin of 67.25%, pointing to lucrative core product margins. A key strength is its strong revenue growth of 9.95% paired with a favorable momentum subScore of 73/100. A significant risk, however, is its exceptionally high debt-to-equity ratio of 6.31 alongside a low safety subScore of 37/100. Evidence is limited to this snapshot date of 2026-10-11.
Written 11/10/2026, 00:23:07 UTC · Snapshot 11/10/2026